Novavax's COVID-19 vaccine approved for Canadians 18 and over Novavax's COVID-19 vaccine has been approved for use in Canadian adults, some 18 months after the federal government had announced a deal to produce the doses in Montreal. February 17, 2022 Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment